Adaptimmune Therapeutics: Custom Miltenyi Suppliers for Innovative Solutions
We are pleased to announce a new collaboration between Adaptimmune Therapeutics and T&L Biotechnology Co., Ltd. to bring cutting-edge immunotherapy products to the market, Adaptimmune Therapeutics is a leader in the development of T-cell receptor-based cancer immunotherapy products, utilizing the body's own immune system to target and destroy cancer cells. T&L Biotechnology Co., Ltd. is a prominent company specializing in biotechnology with a focus on developing innovative cell-based therapies, Together, we are excited to introduce our joint efforts in advancing novel T-cell therapies for the treatment of various cancers. Our collaboration combines Adaptimmune's expertise in T-cell engineering and T&L Biotechnology's proficiency in Cell Therapy manufacturing, allowing us to develop groundbreaking products that have the potential to revolutionize cancer treatment
